Literature DB >> 25176429

Obesity and diabetes: FGF1 goes long to tackle diabetes.

Katie Kingwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25176429     DOI： 10.1038/nrd4419

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer.

Authors:  Jae Myoung Suh; Johan W Jonker; Maryam Ahmadian; Regina Goetz; Denise Lackey; Olivia Osborn; Zhifeng Huang; Weilin Liu; Eiji Yoshihara; Theo H van Dijk; Rick Havinga; Weiwei Fan; Yun-Qiang Yin; Ruth T Yu; Christopher Liddle; Annette R Atkins; Jerrold M Olefsky; Moosa Mohammadi; Michael Downes; Ronald M Evans
Journal:  Nature       Date:  2014-07-16       Impact factor: 49.962
  1 in total
  3 in total

Review 1.  The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.

Authors:  Maitane Izaguirre; María J Gil; Ignacio Monreal; Fabrizio Montecucco; Gema Frühbeck; Victoria Catalán
Journal:  Curr Diab Rep       Date:  2017-06       Impact factor: 4.810

2.  FGF1ΔHBS prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression.

Authors:  Dezhong Wang; Yuan Yin; Shuyi Wang; Tianyang Zhao; Fanghua Gong; Yushuo Zhao; Beibei Wang; Yuli Huang; Zizhao Cheng; Guanghui Zhu; Zengshou Wang; Yang Wang; Jun Ren; Guang Liang; Xiaokun Li; Zhifeng Huang
Journal:  Signal Transduct Target Ther       Date:  2021-03-24

3.  Renal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure.

Authors:  Maciej Tomaszewski; James Eales; Matthew Denniff; Stephen Myers; Guat Siew Chew; Christopher P Nelson; Paraskevi Christofidou; Aishwarya Desai; Cara Büsst; Lukasz Wojnar; Katarzyna Musialik; Jacek Jozwiak; Radoslaw Debiec; Anna F Dominiczak; Gerjan Navis; Wiek H van Gilst; Pim van der Harst; Nilesh J Samani; Stephen Harrap; Pawel Bogdanski; Ewa Zukowska-Szczechowska; Fadi J Charchar
Journal:  J Am Soc Nephrol       Date:  2015-04-27       Impact factor: 10.121
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.